WallStreetZenWallStreetZen

NASDAQ: MASS
908 Devices Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their MASS stock forecasts and price targets.

Forecast return on equity

Is MASS forecast to generate an efficient return?

Company
N/A
Industry
29.11%
Market
159.33%

Forecast return on assets

Is MASS forecast to generate an efficient return on assets?

Company
N/A
Industry
14.36%

MASS earnings per share forecast

What is MASS's earnings per share in the next 2 years based on estimates from 6 analysts?

Avg 1 year Forecast
-$0.48-188.78%
Avg 2 year Forecast
-$0.33-161.39%

MASS revenue forecast

What is MASS's revenue in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
$67.1M+19.44%
Avg 2 year Forecast
$76.8M+36.75%
Avg 3 year Forecast
$88.5M+57.55%
MASS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

MASS revenue growth forecast

How is MASS forecast to perform vs Medical Devices companies and vs the US market?

Company
16.11%
Industry
8.96%
Market
14.02%
MASS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MASS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

MASS vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
MASS$7.09N/AN/A
PROF$7.27$12.00+65.06%Strong Buy
SI$12.92$21.67+67.70%Strong Buy
TLSI$4.61$7.00+51.84%Strong Buy
SGHT$4.33$9.08+109.77%Strong Buy
View Top Medical Device Stocks

908 Devices Stock Forecast FAQ

What is MASS's earnings growth forecast for 2026-2027?

(NASDAQ: MASS) 908 Devices's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 23.89%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 33.69%.

908 Devices's earnings in 2026 is $19,489,000.On average, 6 Wall Street analysts forecast MASS's earnings for 2026 to be -$17,919,949, with the lowest MASS earnings forecast at -$21,979,412, and the highest MASS earnings forecast at -$15,699,580.

In 2027, MASS is forecast to generate -$12,391,454 in earnings, with the lowest earnings forecast at -$12,455,000 and the highest earnings forecast at -$12,167,175.

If you're new to stock investing, here's how to buy 908 Devices stock.

What is MASS's revenue growth forecast for 2026-2028?

(NASDAQ: MASS) 908 Devices's forecast annual revenue growth rate of 16.11% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.96%, and it is also forecast to beat the US market's average forecast revenue growth rate of 14.02%.

908 Devices's revenue in 2026 is $56,197,000.On average, 6 Wall Street analysts forecast MASS's revenue for 2026 to be $2,509,091,965, with the lowest MASS revenue forecast at $2,377,439,771, and the highest MASS revenue forecast at $2,623,100,822. On average, 6 Wall Street analysts forecast MASS's revenue for 2027 to be $2,872,537,248, with the lowest MASS revenue forecast at $2,417,735,360, and the highest MASS revenue forecast at $3,114,871,483.

In 2028, MASS is forecast to generate $3,309,471,519 in revenue, with the lowest revenue forecast at $3,179,688,322 and the highest revenue forecast at $3,406,808,916.

What is MASS's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: MASS) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of 14.36%.

What is MASS's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: MASS) 908 Devices's current Earnings Per Share (EPS) is $0.54. On average, analysts forecast that MASS's EPS will be -$0.48 for 2026, with the lowest EPS forecast at -$0.59, and the highest EPS forecast at -$0.42. In 2027, MASS's EPS is forecast to hit -$0.33 (min: -$0.33, max: -$0.33).

What is MASS's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: MASS) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.